Centrolateral Thalamic Nucleus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The centrolateral thalamic nucleus (CL) is a key component of the intralaminar nuclear complex of the thalamus. It serves as a major relay for ascending arousal signals from the brainstem and plays critical roles in regulating consciousness, attention, and pain processing[1][2]. The CL is strategically positioned to integrate inputs from multiple sources, including the pedunculopontine nucleus, parabrachial nucleus, and cortical regions, making it essential for thalamocortical activation patterns underlying wakefulness and alert behavior[3].
The centrolateral nucleus is located in the medial thalamus, within the intralaminar complex that lies dorsal to the mediodorsal thalamic nucleus. It is composed of medium-sized neurons with extensive dendritic arborizations that receive convergent inputs from diverse brain regions[4]. The CL is divided into caudal and rostral subdivisions, each with distinct connectivity patterns and functional contributions.
The CL projects densely to:
CL neurons exhibit characteristic firing patterns that shift between states of burst and tonic activity. During wakefulness, tonic firing predominates, supporting sustained cortical activation. During non-REM sleep, burst firing becomes more prevalent, contributing to the synchronization of thalamocortical oscillations[15]. This gating mechanism is crucial for maintaining the balance between arousal and sleep.
The CL is a critical driver of thalamocortical oscillations, particularly in the gamma frequency range (30-100 Hz) associated with focused attention and sensory processing[16]. Through its interactions with cortical pyramidal neurons and inhibitory interneurons, the CL helps coordinate the timing of neuronal ensembles necessary for cognitive functions.
In Alzheimer's disease (AD), the centrolateral nucleus shows early pathological changes, including:
CL dysfunction contributes to the characteristic attention and arousal disturbances seen in AD patients, including sundowning syndrome and disrupted sleep-wake cycles[20].
The centrolateral thalamic nucleus is implicated in Parkinson's disease (PD) through:
Deep brain stimulation targeting the thalamus (including CL) has been used to treat tremor in PD, though the precise mechanisms remain under investigation[24].
In multiple system atrophy (MSA), the CL shows:
CL pathology in progressive supranuclear palsy (PSP) includes:
The centrolateral nucleus shows promise as a neuroimaging biomarker:
The CL represents a potential therapeutic target for:
The study of Centrolateral Thalamic Nucleus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Steriade M, Llinás RR. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev. 1988;68(3):649-742. PMID:2836037.
Jones EG. The Thalamus. 2nd ed. Cambridge University Press; 2007.
Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol. 1949;1(4):455-473. PMID:14538494.
Shermana SM. Thalamus. In: Squire LR, editor. Encyclopedia of Neuroscience. Academic Press; 2009:1065-1072.
Garcia-Rill E. The pedunculopontine nucleus. Prog Brain Res. 1991;87:253-268. PMID:1678089.
Willis WD, Coggeshall RE. Sensory Mechanisms of the Spinal Cord. 2nd ed. Plenum Press; 1991.
Goldman-Rakic PS, Porrino LJ. The primate mediodorsal (MD) thalamus and the prefrontal cortex. J Comp Neurol. 1985;242(4):535-560. PMID:2418084.
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-striato-pallido-thalamo-cortical loop. Brain Res Rev. 1995;20(1):91-127. PMID:7711765.
Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18(23):9996-10015. PMID:9822755.
Goldman-Rakic PS. Circuitry of the prefrontal cortex and the regulation of behavior by working memory. In: Uylings HB, editor. The Prefrontal Cortex. Progress in Brain Research. Elsevier; 1996:325-335.
Culham JC, Valyear KF. Human parietal cortex in action. Curr Opin Neurobiol. 2006;16(2):205-212. PMID:16563736.
Haber SN, Calzavara R. The cortico-striatal circuitry. In: Steiner H, Tseng KY, editors. Handbook of Basal Ganglia Structure and Function. Academic Press; 2010:281-301.
LeDoux JE. The emotional brain. Simon & Schuster; 1996.
Saper CB, Fuller PM, Pedersen NP, et al. Sleep state switching. Neuron. 2010;68(6):1023-1042. PMID:21172606.
McCormick DA, Bal T. Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci. 1997;20:185-215. PMID:9056722.
Singer W. Neuronal synchrony: a versatile code for the definition of relations? Neuron. 1999;24(1):49-65. PMID:10677026.
Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(3):389-404. PMID:16906426.
Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42(1):85-94. PMID:9267153.
Zhou J, Greicius MD, Gennatas ED, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain. 2010;133(5):1352-1367. PMID:20410145.
Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs. 2001;15(10):777-796. PMID:11665961.
Jellinger KA. The pedunculopontine nucleus in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):139-158. PMID:17880934.
Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain. 2000;123(9):1767-1783. PMID:10960043.
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912. PMID:25925381.
Benabid AL, Pollak P, Louveau A, et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1-6):344-346. PMID:3329873.
Gilman S, Koeppe RA, Chervin RD, et al. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology. 2003;61(1):43-49. PMID:12847154.
Iranzo A, Santamaria J, Tolosa E. Idiopathic rapid eye movement sleep behavior disorder. Neurol Sci. 2009;30(Suppl 1):S137-S142. PMID:19393457.
Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12(2):133-147. PMID:9087970.
Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44(11):2015-2019. PMID:7969952.
Litvan I. Progressive supranuclear palsy. Curr Opin Neurol. 1998;11(4):351-355. PMID:9748008.
Leigh RJ, Zee DS. The Neurology of Eye Movements. 4th ed. Oxford University Press; 2006.
Callen DJ, Black SE, Gao F, et al. In vivo imaging of cortical lesions in subjects with Alzheimer's disease. Neurology. 2001;57(8):1456-1462. PMID:11673585.
Zhang Y, Schuff N, Du AT, et al. Diffusion tensor imaging of cingulate fibers in the brain in early Alzheimer's disease. Dement Geriatr Cogn Disord. 2009;28(6):524-533. PMID:20016173.
Nordberg A, Rinne JO, Kadir A, et al. The use of PET in Alzheimer disease. Nat Rev Neurol. 2010;6(2):78-87. PMID:20139997.
Nadel L, Hardt O. Update on memory systems and processes. Neuropsychopharmacology. 2011;36(1):251-273. PMID:20980991.
Schiff ND. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci. 2010;33(1):1-9. PMID:19954814.
Casey KL. Pain perception and ascending reticular formation. In: Bonica JJ, editor. Pain. Advances in Neurology. Vol 4. Raven Press; 1974:153-162.
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97(20):11050-11055. PMID:10984517.
Buckner RL, Andrews-Hanna JR, Schacter DT. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124(1):1-38. PMID:18400922.
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306-319. PMID:14991808.
Mori S, van Zijl PC. Fiber tracking: principles and strategies - a technical review. NMR Biomed. 2002;15(7-8):468-480. PMID:12489095.
Jeanmonod D, Magnin M, Morel A. Thalamus and neurogenic pain. In: Besson JM, Guilbaud G, Peschanski M, editors. Thalamus and Pain. Elsevier; 1987:215-231.
Halgren E, Baudena P, Clarke JM, et al. Intracerebral potentials to rare target and distractor auditory and visual stimuli. I. Superior temporal plane and parietal lobe. Electroencephalogr Clin Neurophysiol. 1995;94(4):229-250. PMID:7536470.
Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol. 2007;118(10):2128-2148. PMID:17573239.
Purpura DP. Operations and processes in thalamic and synaptically related neuronal subsystems. In: Schmitt FO, editor. The Neurosciences: Second Study Program. Rockefeller University Press; 1970:458-470.
Huguenard JP, McCormick DA. Electrophysiology of the neuron. In: Schwartzkroin PA, editor. Encyclopedia of Neuroscience. Academic Press; 2009:255-264.
Destexhe A, Sejnowski TJ. Thalamocortical Assemblies: How Ion Channels, Single Neurons, and Network Interactions Shape Cortical Activation. Oxford University Press; 2001.
This page was improved on 2026-03-05.